AzTrials
AzTrials

Condition

Ischemic Stroke Clinical Trials

Studies of ischemic stroke, matched by condition name and medical subject headings. Start with those open to enrolment.

2,840 registered studies

In numbers

Open to volunteers
824
Active
897
With results posted
209
All registered
2,840

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 824
  • Stroke, Ischemic

    Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial

    • Recruiting
    • Age: 75 years and older
    • Phase 3
    • Pill or oral medicine

    The overall aim of this research is to improve secondary stroke prevention for older patients with stroke. In current practice, patients with stroke are often prescribed antiplatelet therapy with either aspirin or clopidogrel to…

    Trial name
    STROKE75+ (NCT07454707)
    Testing
    Edoxaban 15 mg, Aspirin or clopidogrel
    Where
    Canada
    Volunteers
    1,204 people
    Sponsor
    Sunnybrook Health Sciences Centre
    Can I take part? STROKE75+
  • Subarachnoid Hemorrhage, Aneurysmal, Brain Injuries, Traumatic

    Prospective Observational Multimodal Neuromonitoring in Adult NSICU Patients

    • Not yet recruiting
    • Age: 18 years and older
    • Observational study

    This is a prospective observational cohort study of adult patients admitted to the Neurosciences Intensive Care Unit (NSICU) at UT Southwestern Medical Center.

    Conditions
    Subarachnoid Hemorrhage, Aneurysmal, Brain Injuries, Traumatic, Cerebral Hemorrhage, Ischemic Stroke
    Trial name
    NCT07577713
    Where
    United States
    Volunteers
    300 people
    Sponsor
    University of Texas Southwestern Medical Center
    Can I take part? NCT07577713
  • Acute Ischemic Stroke

    Prehospital Response and Emergency Stroke Transport Optimisation

    • Not yet recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    This study aims to develop and evaluate an innovative prehospital emergency transport system for patients with acute ischemic stroke to reduce delays in reperfusion treatment.

    Trial name
    PRESTO (NCT07892053)
    Testing
    Innovative pre-hospital emergency transport system for acute ischemic stroke
    Where
    China
    Volunteers
    320 people
    Sponsor
    Xuanwu Hospital, Beijing
    Can I take part? PRESTO
  • Ischemic Stroke

    Stroke-induced Myocardial Dysfunction: Role of GDF-15 (SMOG-15) Clinical Work Package

    • Recruiting
    • Age: 18 years and older
    • Observational study
    • Surgery or procedure

    The aim of this study is to analyze the relationship between the blood biomarker GDF-15 and heart damage after stroke. It is being conducted in France, in the Neurology Department of the Dijon University Hospital (Burgundy).

    Trial name
    SMOG-15 (NCT05683873)
    Testing
    Electrocardiogram, transthoracic echocardiography, standard biology
    Where
    France
    Volunteers
    130 people
    Sponsor
    Centre Hospitalier Universitaire Dijon
    Can I take part? SMOG-15
  • Acute Ischemic Stroke, Large Vessel Occlusion

    Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular Events

    • Recruiting
    • Age: 18 years and older
    • Phase 3
    • Injection or infusion
    • Surgery or procedure

    Acute ischemic stroke caused by large vessel occlusion (LVO) is a major cause of disability, and mechanical thrombectomy (MT) has become the standard treatment for eligible patients.

    Conditions
    Acute Ischemic Stroke, Large Vessel Occlusion, Anterior Circulation Brain Infarction
    Trial name
    TRACE- BRIDGE (NCT07748039)
    Testing
    rhTNK-tPA (0.25mg/kg), Reteplase 10 Units (U) plus a second dose of reteplase 10 U, No thrombolysis (thrombectomy alone)
    Where
    5 sites in China
    Volunteers
    1,440 people
    Sponsor
    Yongjun Wang
  • Intracranial Atherosclerosis, Intracranial Arterial Stenosis

    EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease

    • Not yet recruiting
    • Age: 18 to 90 years
    • Surgery or procedure

    ERSIAS IIb is a multicenter randomized controlled trial, with a Phase IIb design, to find out whether encephaloduroarteriosynangiosis (EDAS), a type of indirect surgical revascularization of the brain, added to intensive medical…

    Conditions
    Intracranial Atherosclerosis, Intracranial Arterial Stenosis, Ischemic Stroke
    Trial name
    ERSIAS IIb (NCT07864649)
    Testing
    Encephaloduroarteriosynangiosis (EDAS), Intensive medical management
    Volunteers
    170 people
    Sponsor
    Cedars-Sinai Medical Center
    Can I take part? ERSIAS IIb
  • Acute Ischemic Stroke

    A Study to Evaluate the Intracranial Arterial Recanalization With Multiple Doses of LT3001 Drug Product in AIS Participant

    • Recruiting
    • Age: 18 to 88 years
    • Phase 2
    • Injection or infusion

    This is a phase II, open-label, single-arm, exploratory study to evaluate the intracranial arterial recanalization of multiple doses of LT3001 drug product in participant with acute ischemic stroke (AIS)

    Trial name
    NCT07890298
    Testing
    LT3001 Drug Product
    Where
    Taiwan
    Volunteers
    10 people
    Sponsor
    Lumosa Therapeutics Co., Ltd.
    Can I take part? NCT07890298
  • Acute Ischemic Stroke

    Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions

    • Recruiting
    • Age: 18 to 85 years
    • Medical device

    The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal.

    Trial name
    TURBO (NCT06029491)
    Testing
    RapidPulseTM Aspiration System
    Where
    30 sites in United States, France and 2 more
    Volunteers
    170 people
    Sponsor
    RapidPulse, Inc
    Can I take part? TURBO
  • Acute Ischemic Stroke AIS, Stroke Acute

    ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

    • Recruiting
    • Age: 18 years and older
    • Phase 3
    • Injection or infusion

    This domain has a prospective, randomized, controlled, open-label, parallel group with blinded endpoint assessment (PROBE) design.

    Conditions
    Acute Ischemic Stroke AIS, Stroke Acute, Stroke, Acute, Stroke Ischemic
    Trial name
    ACT-WHEN (NCT06320431)
    Testing
    Tenecteplase
    Where
    24 sites in Australia, Canada
    Volunteers
    4,000 people
    Sponsor
    University of Calgary
    Can I take part? ACT-WHEN
  • Stroke, Stroke (CVA) or Transient Ischemic Attack

    Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke

    • Recruiting
    • Age: 18 to 75 years
    • Medical device

    Our proposed study, "NEUROBALANCE Stroke,"; aims to evaluate the effectiveness of a combined intervention involving robotic balance training and noninvasive brain stimulation in improving balance function and postural control in…

    Conditions
    Stroke, Stroke (CVA) or Transient Ischemic Attack, Stroke Ischemic, Stroke Gait Rehabilitation
    Trial name
    NEUROBALANCE (NCT07113041)
    Testing
    Combined (Robotic balance training and high-definition transcranial direct current stimulation), Standard of Care Balance Training
    Where
    United States
    Volunteers
    45 people
    Sponsor
    Kessler Foundation

Completed, with results posted

All –
  • Cerebral Palsy, Stroke

    Spinal Stimulation and Mobility Devices

    • Completed
    • Age: 4 to 70 years
    • Medical device
    • Results posted

    This research study will combine non-invasive spinal stimulation with an ankle exoskeleton to examine the acute impact of the stimulation on gait in children with cerebral palsy.

    Conditions
    Cerebral Palsy, Stroke, Premature Birth, Hypoxic-Ischemic Encephalopathy
    Trial name
    NCT05520359
    Testing
    Mobility Device, Spinal Stimulation
    Where
    United States
    Volunteers
    10 people
    Sponsor
    University of Washington
    Can I take part? NCT05520359
  • Stroke, Stroke, Ischemic

    At-Home taVNS - Stroke Rehab

    • Completed
    • Age: 18 to 80 years
    • Medical device
    • Results posted

    Early evidence suggests the benefits of post-stroke motor rehabilitation may be enhanced by applying electrical stimulation to the ear.

    Conditions
    Stroke, Stroke, Ischemic, Stroke Hemorrhagic
    Trial name
    NCT06616831
    Testing
    Remote Transcutaneous Auricular Vagal Nerve Stimulation Paired with Task-Specific Training
    Where
    United States
    Volunteers
    5 people
    Sponsor
    Medical University of South Carolina
    Can I take part? NCT06616831
  • Cerebrovascular Disorders, Smoking Cessation

    Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease

    • Completed
    • Age: 18 years and older
    • Phase 4
    • Results posted

    Research Aims The aims of this research study are to determine whether cost-free smoking cessation pharmacotherapy: 1. Helps smokers with Transient Ischemic Attack (TIA) or stroke to quit smoking over the long-term, compared to…

    Trial name
    NCT00962988
    Testing
    Cost-Free Pharmacotherapy Group, Prescription Only Group
    Where
    2 sites in Canada
    Volunteers
    194 people
    Sponsor
    Ottawa Heart Institute Research Corporation
    Can I take part? NCT00962988
  • Ischemic Stroke

    Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial

    • Completed
    • Age: 18 to 85 years
    • Phase 2
    • Results posted

    Prospective, single center, non-randomized, pilot study to assess the feasibility of IA TNK following standard of care mechanical thrombectomy (MT) in patients with AIS.

    Trial name
    ALLY (NCT05172934)
    Testing
    intra-arterial tenecteplase
    Where
    United States
    Volunteers
    20 people
    Sponsor
    ProMedica Health System
    Can I take part? ALLY
  • Cardiovascular Diseases, Myocardial Infarction

    Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination

    • Completed
    • Age: 65 years and older
    • Lifestyle or therapy programme
    • Results posted

    This pragmatic clinical trial embedded in an accountable care organization will determine the comparative effectiveness of two approaches for assigning care coordinators to older adults at risk for cardiovascular outcomes.

    Conditions
    Cardiovascular Diseases, Myocardial Infarction, Atrial Fibrillation, Diabetes Mellitus
    Trial name
    NCT05820295
    Testing
    Care coordination delivered based on perceived need, Care coordination delivered based on usual care (e.g. discharge from hospital)
    Where
    United States
    Volunteers
    400 people
    Sponsor
    Weill Medical College of Cornell University
    Can I take part? NCT05820295

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in